Treasury Wine Estates (ASX:TWE) reaffirms FY25 EBITS guidance range of AUD 780-810Mn

Treasury Wine Estates Limited (ASX:TWE) is engaged in grape growing and sourcing, wine production, and wine marketing, sales, and distribution. The company has three divisions - Treasury Premium Brands, Treasury Americas and Penfolds. In the financial year 2024 (FY24), Penfolds achieved a significant milestone …

Team Kalkine | 16 Dec 2024| Read Time : 10 Mins

Iluka Resources (ASX: ILU) Declares 33% Higher Interim Dividend of 4cps in 1HFY24 Amid 34% NPAT Drop

Iluka Resources Ltd (ASX:ILU) is an ASX-listed global mineral sands company that is engaged in the exploration, mining, project development, marketing and processing of zircon and titanium dioxide feedstocks. Eneabba Rare Earths Refinery project The company is expanding into the rare earth sector. The …

Team Kalkine | 11 Dec 2024| Read Time : 10 Mins

Northern Star Resources (ASX:NST) eyes significant growth with De Grey Mining acquisition and KCGM Mill Expansion

Northern Star Resources Limited (ASX:NST) is an ASX-listed gold production company, involved in the development, mining, and processing of gold deposits in Western Australia, the Northern Territory, and Alaska. Recently, the company announced the acquisition of De Grey Mining, an ASX-listed company, via a …

Team Kalkine Media | 10 Dec 2024| Read Time : 10 Mins

Lycopodium (ASX:LYL) forecasts FY25 revenue of AUD 345–360Mn with NPAT of AUD 40-45Mn

Lycopodium Limited (ASX:LYL) is an Australia-based company that offers integrated engineering, construction, and asset management solutions. The company handles complex, multidisciplinary projects by providing feasibility studies and advisory services across the resources, rail infrastructure, and industrial processes industries. In the financial year 2024 (FY24), …

Team Kalkine | 09 Dec 2024| Read Time : 10 Mins

Neuren Pharmaceuticals (ASX: NEU) Raises FY24 North America DAYBUETM Commercial Income Guidance to AUD 132-138Mn

Neuren Pharmaceuticals Limited (ASX:NEU) develops new drug therapies for the treatment of neurological disorders. DAYBUE™ (trofinetide) is a product of NEU that has received US FDA approval. It is designed to treat Rett syndrome in patients who have attained the age of two years …

Team Kalkine | 04 Dec 2024| Read Time : 10 Mins

West African Resources (ASX:WAF) plans to launch its largest-ever drilling campaign in 2025

West African Resources Ltd (ASX:WAF) is a West Africa-focused company that acquires, explores and develops gold projects. Over the next decade, the company targets gold production of over 450,000 ounces every year with peak production of 494,000 ounces in 2030. The 10-year production forecast …

Team Kalkine | 03 Dec 2024| Read Time : 10 Mins

COG Financial Services (ASX: COG) Reports 36% Revenue Growth in FY24, Eyes Organic Growth and Strategic Acquisitions

COG Financial Services Limited (ASX:COG) is an Australia-based finance aggregator and equipment leasing firm that mainly offers services to small and medium enterprises. In the financial year 2024 (FY24), the company reported revenue of AUD 495.6 million, reflecting a rise of 36% YoY. The …

Team Kalkine Media | 02 Dec 2024| Read Time : 10 Mins

News